Sign Up to like & get
recommendations!
0
Published in 2018 at "Nature Communications"
DOI: 10.1038/s41467-018-06271-5
Abstract: Controlling the biodistribution of nanoparticles upon intravenous injection is the key to achieving target specificity. One of the impediments in nanoparticle-based tumor targeting is the inability to limit the trafficking of nanoparticles to liver and other…
read more here.
Keywords:
engineered antibody;
ultrasmall targeted;
targeted nanoparticles;
her2 ... See more keywords